High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
GDX delivered 44.4% returns over the past year but experienced a 46.5% drawdown, while GLD's lower volatility came with 21.4% gains.
State Street's financial ETF charges just 0.08% annually, while ProShares' leveraged alternative targets double daily returns at a steeper 0.94% cost.
XYLD has a loyal following and a 10% yield, but a growing roster of covered call ETFs undercuts its fee while offering features it simply cannot match. Before committing capital, knowing exactly where each fund wins and loses changes everything.
VT's lower 0.06% expense ratio and stronger 5-year returns make it the cost-efficient choice, while EEM offers concentrated emerging market exposure with higher near-term gains.
iShares dominates with $47B in assets, while VanEck undercuts on fees at 0.20% versus 0.25%. Which matters more for your portfolio?
Tech giants now control nearly half the S&P 500, surpassing even dot-com bubble levels, and the AI spending race is raising uncomfortable questions about what happens when a handful of companies drive the fate of an entire index.
Pfizer's dividend yield is 7% for a very good reason: investors are worried about the risk of a dividend cut.
A covered-call ETF built on small caps instead of Big Tech is dangling a 13% yield, but the tradeoffs hiding behind that number could make or break your portfolio depending on how you hold it.
A portfolio of dividend payers with decade-long track records is outrunning the AI-heavy growth indexes.
These stocks pay high-yielding, steadily rising dividends.
IYK delivered 8.3% returns over one year with a 2.5% dividend yield, while maintaining broader sector diversification across household products and tobacco alongside food and beverage stocks.
July has a long history of punishing investors who mistake a good run for a durable business. Three Dividend Kings have kept raising their payouts through every major crash since 1987, and all three just delivered beat-and-raise quarters heading into a summer that already feels shaky.
The S&P 500 is in an earnings boom — but the usual earnings bust never came.
IBBQ's concentrated biotech play has delivered a higher one-year return, while IXJ'S diversified global healthcare fund has been much less volatile.
No one ever said overseeing monetary policy for the world's largest economy would be easy.
Recent Stock Interest and Earnings Outlook Badger Meter (BMI) has drawn fresh investor attention after its stock outperformed the Zacks S&P 500 composite and its industry group, even as forecasts point to lower earnings for the current quarter and fiscal year. Expectations for an earnings increase in the next fiscal year, along with a Zacks Rank #3 (Hold) that signals potential performance roughly in line with the broader market, position Badger Meter as a stock many investors are...
Things have turned out OK, even as the outlook for U.S. farmers arguably got worse, not better, over the past year. Deere stock still looks like a winner. Deere traded above $670 in early 2026 as investors eyed a rebound in farm income that would lead to more tractor purchases.
The stock market's No. 1 catalyst has quickly transformed into an inflationary menace.
Not surprisingly, Warren Buffett looks on the bright side of market crashes.
Arch Capital Group (ACGL) has drawn fresh attention after a 9.7% gain over the past month, outpacing both the Zacks S&P 500 composite and the broader property and casualty insurance group. See our latest analysis for Arch Capital Group. At a share price of $101.35, Arch Capital Group has seen momentum build recently, with a 9.7% 30 day share price return and a 14.71% one year total shareholder return. The five year total shareholder return of 176.62% highlights how long term holders have been...
Micron and Nvidia look like great deals now -- and despite its recent stellar gains, so does Sandisk.
DIVO's covered-call strategy looks solid on paper, but two macro forces are quietly working against its monthly payouts in ways most income investors overlook. Here is what the options chain and the Treasury market are signaling right now.
The company agreed to take on a large stake in a series of oil plays in northern Iraq.
REVIEW PREVIEW NEWSLETTER Summer Repeat. It sounds like a broken record, but once again tech was the reason behind the market’s downbeat end to the week. Insurance earnings helped rescue the Dow Jones Industrial Average from an even bigger decline.
The healthcare giant's stock jump was about more than an earnings beat, offering proof of a growth story broader and more resilient than you thought.
In the latest trading session, Equinix (EQIX) closed at $1, marking a +1.08% move from the previous day.
Can we count your visit with Google Analytics? No ads, no profiles. Details
